Recursos

Emergency aortic stent-graft treatment for malignant aortoesophageal fistula.

Related Articles Emergency aortic stent-graft treatment for malignant aortoesophageal fistula. Asian Cardiovasc Thorac Ann. 2017 Nov;25(9):649-652 Authors: Wong PC, Chan YC, Law Y, Keung Cheng SW Abstract Two patients with locally advanced squamous cell carcinoma of the mid-esophagus, with esophageal stents in situ, suffered sudden onset of massive hematemesis and hemodynamic instability due to an aortoesophageal fistula. Although their esophageal neoplasms were deemed inoperable and treatment was palliative, the bleeding was successfully stopped with an endovascular aortic stent-graft. They both remained stable with no septic or hemorrhagic complications, and survived for 14 and 16 weeks after the operation. We emphasize…
Origen: Emergency aortic stent-graft treatment for malignant aortoesophageal fistula. – PubMed

Leer más

Recursos

Endoscopic biliary stenting for unresectable malignant hilar obstruction.

Related Articles Endoscopic biliary stenting for unresectable malignant hilar obstruction. Clin J Gastroenterol. 2017 Dec;10(6):485-490 Authors: Fukasawa M, Takano S, Shindo H, Takahashi E, Sato T, Enomoto N Abstract Palliative drainage is the primary treatment option for unresectable malignant hilar biliary obstruction (UMHBO) to improve the prognosis and quality of life. Currently, endoscopic biliary drainage is considered as a first-line treatment for UMHBO as well as for distal biliary obstruction. Self-expanding metal stents (SEMSs) are preferred over plastic stents (PSs) in patients with life expectancy of >3 months. However, endoscopic treatment of UMHBO is often more challenging and complex than that…
Origen: Endoscopic biliary stenting for unresectable malignant hilar obstruction. – PubMed

Leer más

Recursos

Attitudes of Older Chinese Patients Toward Death and Dying.

Related Articles Attitudes of Older Chinese Patients Toward Death and Dying. J Palliat Med. 2017 Dec;20(12):1389-1394 Authors: Chen Q, Flaherty JH, Guo JH, Zhou Y, Zhang XM, Hu XY Abstract BACKGROUND: Due to the aging population of China, the need for palliative care will increase. However, one of the barriers to utilization of palliative care is the traditional belief that talking about death and dying is taboo. OBJECTIVE: The aim of this study was to examine to what extent older Chinese patients were willing to answer questions about death and dying by asking them about “fear of death” and their…
Origen: Attitudes of Older Chinese Patients Toward Death and Dying. – PubMed

Leer más

Recursos

The Complex Needs of Pediatric Hematopoietic Stem Cell Donors and Their Families: Challenges and Opportunities.

Related Articles The Complex Needs of Pediatric Hematopoietic Stem Cell Donors and Their Families: Challenges and Opportunities. J Pediatr. 2016 11;178:14-15 Authors: Derrington SF, Essner BS PMID: 27597732 [PubMed – indexed for MEDLINE]
Origen: The Complex Needs of Pediatric Hematopoietic Stem Cell Donors and Their Families: Challenges and Opportunities. – PubMed

Leer más

Recursos

Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases.

Related Articles Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases. Ann Palliat Med. 2017 Dec;6(Suppl 2):S233-S239 Authors: Furfari A, Wan BA, Ding K, Wong A, Zhu L, Bezjak A, Wong R, Wilson CF, DeAngelis C, Azad A, Chow E, Charames GS Abstract BACKGROUND: Palliative radiotherapy (RT) is effective in patients with painful bone metastases. Genetic factors may identify subgroup of patients who responded to RT. To identify DNA biomarkers associated with response to palliative RT. METHODS: Patients who received a single 8 Gy dose of RT for painful bone metastases were categorised into responders…
Origen: Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases. – PubMed

Leer más

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies